Insight Molecular Diagnostics launches 5,000-patient registry study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. DE

Go back to Insight Molecular Diagnostics launches 5,000-patient registry study
(NASDAQ: IMDX) Delayed: 4.34 +0.04 (0.93%)
Previous Close $4.30    52 Week High $ 
Open $4.40    52 Week Low $ 
Day High $4.46    P/E N/A 
Day Low $4.31    EPS $ 
Volume 38,690